News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|December 23, 2015

Hot Topics of 2015

Author(s)Natalie Timoshin

We invite you to reflect on your diagnostic understanding of topics presented this year.

Best of Psychiatric Times in 2015.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression

Sleep, Cognition, and the Bidirectional Brain, With Michael Scullin, PhD

Transcranial Direct Current Stimulation to Enhance Brain Activity: Applicability for Schizophrenia

How Sleep Conditions Predict the Likelihood and Severity of Falls in Older Adults